Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.55 |
| ▸ | CTSS | P25774 | 16/20 | 0.53 |
| ▸ | CTSK | P43235 | 13/20 | 0.53 |
| ▸ | CTSB | P07858 | 4/20 | 0.50 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31757439 | 0.92 | TRPA1 (0.56) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL29919594 | 0.91 | TRPA1 (0.55) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL25152869 | 0.91 | TRPA1 (0.55) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL21639070 | 0.87 | CTSS (0.57) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL21639072 | 0.87 | CTSS (0.57) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL29529102 | 0.86 | CTSS (0.51) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL21689270 | 0.83 | CTSS (0.57) | CTSSCTSKCTSBCTSLPTPN1 | |
| SCHEMBL21663693 | 0.83 | CTSS (0.57) | CTSSCTSKCTSBCTSLPTPN1 | |
| SCHEMBL12648001 | 0.82 | TRPA1 (0.51) | TRPA1CTSSCTSKCTSBCTSL | |
| SCHEMBL29529364 | 0.82 | CTSS (0.47) | TRPA1CTSSCTSKCTSBCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3604326-B1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORP (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | TRPA1 135/4885CTSS 2496/4885CTSK 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.